Company in teleconference said top line data is extremely encouraging, more data over next few weeks. May not need to raise capital. Replay is availble at co. website, I'm listening now
Oxford is onboard, a believer, and any financing may not hurt the stock much, can't guess well yet.
I just got a small starter, will await further developments. Fast Track status helps, too.
The reaction to today's p2 results I think is partially due to it's so unknown by Americans at least.
I bought vphm in 2004, owned rights to vancomycin, merged with Lev which I also owned, then vphm got bought for $4.2B, of course I sold it long before the buyout. This one can really shine longer term.
I took a quick look and got a small starter today at $10.70, I post at investor village, free to join and post there, I just put up msg no. 2 there, so much better website code than yazoo. This company appears to be a secret, today at least.
No one knows why. I hate yahoo, hate to sign in to chat here, why don't you join free the far superior website IV? I know the site is better, not commenting on quality of posts. Some think ya gotta pay IV but that hasn't been true except for about a year, ended long ago. PRs only skim the surface, so if investing, best to read the filings, if trading, use the charts. Telec. are valuable too for investors. Replay is available, should have q&a, this last one didn't have much info.
I think it's the penny flippers who but burned, taking losses, may be Promed, Ed posted he thinks muskat is dumping, might be both. Need fundies to improve to improve chart.
gthp hired irth, aquarius paid for it, and also paid for the pumpjobs.
That is my belief, no proof. Makes perfect sense that it's true.
Anyone with any intelligence at all knows pennypump letters do not
bring serious, long term, investors. This is what can happen
when cos. deal with loan sharks. Those appear over now, as co. is finally willing
to bet the ranch on a new loan by pledging IP as collateral.
Sure seems Chinese ent. are serious about dist there. I expect an announcement this year, but wtf knows, too many delays/disappointments.
No, Disc, think more deeply: GTHP is broke, Aquarius hired IRTH and paid them, also paid for the pumpjobs which succeeded in helping them unload. gthp went along with it,
but didn't participate. gthp cannot control aquarius, even if they signed an agreement not to do something, like sell more than 15% of daily volume, no way to prove or stop or enforce that.
I think Aquarius had a LOT to do with the pennypumps which are atrocious. They needed buyers to dump millions of shares to. FDA should not care one bit about the stock price and balance sheet and I surely doubt they do care.
then a small sell last trade. Kingsalt, don't infer too much into what I write, I'm honest,
I know this dog has fleas but yo there are meds for that, like one more big contract SOON.
CFO doesn't seem too sharp.
Let's see what the big shareholders do now that the discount is set.
Those financing filings, preferreds, warrants, are a trip.
One day at a time then we die, companies do that too,mostly. Kodak anyone? Polaroid? The names live on...even Chinese bought up Hoover vacuums, I bought a Dyson, it will outlast me and it really sucks! DC33 for $330, what a deal, I even vacuumed my garage, next the front lawn.
Colonscopies the other biggie.
99% is so ridiculous and FDA knows it.
Funny that CFO Rufai does not know the FD share count, maybe he can hire a Pro
to calculate it for him?
It was discussed at SH mtg, per iHub poster that was reposted at gthp iv board,
med device vs diagnostic.
Let's see what happens, time is surely running out, Gene said he got an offer for China
just this morn and hasn't studied it in detail yet, not sure if it's acceptable.
As for Kenya surprise me, it seems like a pipe dream at this point,
Smokin' that Hopium.
btw, that Roche test is very expensive, the machines are unaffordable.
Plus Luviva showed true cancer positives that hpv tests missed, per recent PR about Kenyan MoH.
The Trovagene urine test is also very expensive and requires all testing done
at their lab in California, lot of shipping, waiting, and patients lost to followups in
Lots of theories, Mr. Salt, remember there were numerous pennypumper letters and huge
volumes - Aquarius began selling into that heavily over a dime, Turkey order news, and all the way down to the pennyletter flippers who got burned as price didn't rise much, and later dumped.
These are pennyflippers who sub to the letters for quickie trades, not investors. One other big rumored to be dumping for whatever reasons. For the past year same thing: It all boils down to can they get enough CG biz to be profitable on an operating cash flow basis. They are about 40% of the way there for 2016 with Turkey order. Will need more than $10m sales due to high interest payments. Still, every share sold is one bought, partly traders. Time is running out on 2015 yet no news we've been awaiting.
Ok, Alex, I'll take 3 flying pigs for $500
and the answer IS!
Something that drifted out of an opium pipe.
What is Gene's fantasy about another big contract?
The Turkey order is profitable. They're making about 60% gross margin on the cervical guides and breaking even on the Luvivas. CG costs drop beginning Dec., switching to 1 cap per 100 instead of one cap each, bringing cost of CG under $3. Last batch announced, an increase in original order, sold for $6.77. Company needs new big orders or licensing STAT.
Ed, chill out and DO NOT MISQUOTE ME like that....I wrote "as FAR as I know".
I'm looking at the income statement, cash flow statement, next year with both turkey and kenya shipping. The stock may not do great for a while but that would fix things up quite a lot IF they both ship as planned.
As long as they can pay their bills all it needs is one more big order and problems can be
easily solved. I've seen many companies in dire straits pull one out of the fire.
As far as I know the Kenya order will happen and it will be soon, this year for sure. The other deals are being discussed now but nothing immediate is expected, though this year is still possible if parties can come to terms. Gene is talking to every company he knows about all sorts of things. Slow revenues has caused the ugly balance sheet and capital structure but 1M cervical guides a year would make it well and that's no pipe dream.
They'll make almost $4 GM each on the CG, cost under $3 and sold for $6.77, times 20M over 3 yrs. Just guessing on how many total but could be well over 3m/year.
I hate yahoo, stupid red lite whenever a reply or thumb to my post, now can't turn it off. long threads with disappearing posts, censors, posts get deleted if punctuations yazoo dislikes, it's a mess here. Can't tolerate it. Go to investor village. Go study those filings, get out your calculator, get help, LWE tried to help you. Ed tried, I tried.